| 标题 |
[求助补充材料]
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study |
| 网址 | |
| DOI | |
| 其它 | Zhang J, Meng Y, Du Y, Sun T, Cui J, Chen Y, Sun Y, Wang Y, Chen W, Xu F, Shi Y, Chen Y, Wang K, Jin G, Zhou H, Zhuang Z, Xie W, Wang Z, Sun M, Wen Q, Wang X, Wang C, Xiao S, Zhu H, Zhu Y, Wu J. Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study. Ann Oncol. 2026 Sep 11:S0923-7534(26)06634-2. doi: 10.1016/j.annonc.2026.09.002. Epub ahead of print. PMID: 42727637. |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)